UroGen Pharma Ltd. (URGN)

UroGen Pharma Revenue

UroGen Pharma had revenue of $25.20M in the quarter ending September 30, 2024, with 20.87% growth. This brings the company's revenue in the last twelve months to $89.36M, up 15.64% year-over-year. In the year 2023, UroGen Pharma had annual revenue of $82.71M with 28.52% growth.

• Revenue (ttm): $89.36M
• Revenue Growth: +15.64%
• P/S Ratio: 4.45
• Revenue / Employee: $444,592
• Employees: 201
• Market Cap: 449.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	82.71M	18.36M	28.52%
Dec 31, 2022	64.36M	16.32M	33.96%
Dec 31, 2021	48.04M	36.24M	307.17%
Dec 31, 2020	11.80M	11.78M	65,450.00%
Dec 31, 2019	18.00K	-1.11M	-98.40%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.